Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience

Journal of Magnetic Resonance Imaging

Volumn 29, Issue 6, 2009, Pages 1317-1322

  Baxter, Simon ^a   Wang, Zhen J ^a,c   Joe, Bonnie N ^a   Qayyum, Aliya ^a   Taouli, Bachir ^b   Yeh, Benjamin M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cirrhosis; Dynamic contrast enhanced MRI; Liver; MR perfusion; Timing bolus

Indexed keywords

GADODIAMIDE;

ARTERY BLOOD FLOW; ARTICLE; BLOOD VOLUME; CLINICAL EXAMINATION; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HUMAN; LIVER CIRRHOSIS; LIVER PERFUSION; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; LIVER; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 66749160247     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21795     Document Type: Article

References (15)

1. Heron M. Deaths: leading causes for 2004. Natl Vital Stat Rep 2007;56:1-95.
2. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618.
3. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457. (Pubitemid 37466971)
4. Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993;118:96-98.
5. Richter S, Mucke I, Menger MD, Vollmar B. Impact of intrinsic blood flow regulation in cirrhosis: maintenance of hepatic arterial buffer response. Am J Physiol Gastrointest Liver Physiol 2000;279: G454-G462.
6. Gulberg V, Haag K, Rossle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 2002;35: 630-634. (Pubitemid 34183968)
7. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229:409-414. (Pubitemid 37310826)
8. Materne R, Smith AM, Peeters F, et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002; 47:135-142. (Pubitemid 34019702)
9. Van Beers BE, Materne R, Annet L, et al. Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrast-enhanced MRI in the rabbit. Magn Reson Med 2003;49:692-699. (Pubitemid 36389979)
10. Hagiwara M RH, Lee VS, Losada M, Bannan MA, Krinsky GA, Taouli B. Advanced liver fibrosis: diagnosis with 3D whole liver perfusion MR imaging initial experience. Radiology 2008;246:926-934.
11. Ito K, Mitchell D, Siegelman E. Cirrhosis: MR imaging features. Magn Reson Imaging Clin N Am 2002;10:75-92, vi.
12. Kamath PS, Kim WR. The model for end-stage liver disease (MELD). Hepatology 2007;45:797-805. (Pubitemid 46450631)
13. Bokacheva L, Rusinek H, Chen Q, et al. Quantitative determination of Gd-DTPA concentration in T1-weighted MR renography studies. Magn Reson Med 2007;57:1012-1018. (Pubitemid 46915356)
14. Jones RA, Easley K, Little SB, Scherz H, Kirsch AJ, Grattan-Smith JD. Dynamic contrast-enhanced MR urography in the evaluation of pediatric hydronephrosis: Part 1. Functional assessment. AJR Am J Roentgenol 2005;185:1598-1607.
15. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-259. (Pubitemid 29463107)